| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)
|
Zhou, Qing
|
|
2014
|
83 |
3 |
p. 369-373
5 p.
|
artikel
|
| 2 |
Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer
|
Kimura, Hideharu
|
|
2014
|
83 |
3 |
p. 329-333
5 p.
|
artikel
|
| 3 |
Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients
|
Xu, Songxiao
|
|
2014
|
83 |
3 |
p. 341-346
6 p.
|
artikel
|
| 4 |
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
|
Kim, Min Hwan
|
|
2014
|
83 |
3 |
p. 389-395
7 p.
|
artikel
|
| 5 |
Contents
|
|
|
2014
|
83 |
3 |
p. vi-vii
nvt p.
|
artikel
|
| 6 |
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
|
Macerelli, M.
|
|
2014
|
83 |
3 |
p. 383-388
6 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2014
|
83 |
3 |
p. iii-
1 p.
|
artikel
|
| 8 |
Epithelial–myoepthelial carcinoma of the tracheobronchial tree: The prognostic role of myoepithelial cells
|
Song, Dae Hyun
|
|
2014
|
83 |
3 |
p. 416-419
4 p.
|
artikel
|
| 9 |
Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: A registry study
|
Rasmussen, Jakob F.
|
|
2014
|
83 |
3 |
p. 347-355
9 p.
|
artikel
|
| 10 |
High-dose, conventionally fractionated thoracic reirradiation for lung tumors
|
Griffioen, Gwendolyn H.M.J.
|
|
2014
|
83 |
3 |
p. 356-362
7 p.
|
artikel
|
| 11 |
How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study
|
Husain, Aliya N.
|
|
2014
|
83 |
3 |
p. 324-328
5 p.
|
artikel
|
| 12 |
Molecular testing in oncology: Problems, pitfalls and progress
|
O’Brien, Cathal P.
|
|
2014
|
83 |
3 |
p. 309-315
7 p.
|
artikel
|
| 13 |
Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry
|
Seo, An Na
|
|
2014
|
83 |
3 |
p. 316-323
8 p.
|
artikel
|
| 14 |
Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient
|
Pircher, A.
|
|
2014
|
83 |
3 |
p. 408-410
3 p.
|
artikel
|
| 15 |
Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement
|
Ha, Sang Yun
|
|
2014
|
83 |
3 |
p. 411-415
5 p.
|
artikel
|
| 16 |
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
|
Kim, Hye Ryun
|
|
2014
|
83 |
3 |
p. 374-382
9 p.
|
artikel
|
| 17 |
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
|
Reinmuth, N.
|
|
2014
|
83 |
3 |
p. 363-368
6 p.
|
artikel
|
| 18 |
Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients – Analysis based on the National Lung Cancer Audit
|
Beckett, P.
|
|
2014
|
83 |
3 |
p. 396-400
5 p.
|
artikel
|
| 19 |
The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation
|
Duruisseaux, Michael
|
|
2014
|
83 |
3 |
p. 334-340
7 p.
|
artikel
|
| 20 |
Treatment and survival disparities in lung cancer: The effect of social environment and place of residence
|
Johnson, Asal Mohamadi
|
|
2014
|
83 |
3 |
p. 401-407
7 p.
|
artikel
|
Tijdschrift beschrijving